{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:13:10Z","timestamp":1784362390138,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":872,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbmt.2020.09.029","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T19:06:45Z","timestamp":1601406405000},"page":"72.e1-72.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience"],"prefix":"10.1016","volume":"27","author":[{"given":"Anna B.","family":"Pawlowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith K.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarke P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie F.","family":"DiMundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Femino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J'Rick","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dagis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Miser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2020.09.029_bib0001","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdp155","article-title":"Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Paulussen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0002","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0959-8049(01)00131-9","article-title":"Treatment strategies for metastatic Ewing's sarcoma","volume":"37","author":"Pinkerton","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0003","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pbc.23040","article-title":"Risk of recurrence and survival after relapse in patients with Ewing sarcoma","volume":"57","author":"Stahl","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mpo.10248","article-title":"Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma","volume":"40","author":"Shankar","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cncr.10192","article-title":"Survival after recurrence of Ewing tumors: the St. Jude children's research hospital experience, 1979-1999","volume":"94","author":"Rodriguez\u2010Galindo","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0006","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/annonc\/mdg457","article-title":"Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997","volume":"14","author":"Bacci","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/bmt.2008.169","article-title":"High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors","volume":"42","author":"Rosenthal","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2640674","article-title":"Role of high-dose chemotherapy and autologous hematopoietic cell transplantation for children and young adults with relapsed Ewing's sarcoma: a systematic review","volume":"2018","author":"Tenneti","year":"2018","journal-title":"Sarcoma"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose: a critical factor in cancer chemotherapy","volume":"69","author":"Frei","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0010","article-title":"Role of high dose chemotherapy and autologous stem cell transplant in relapsed Ewing's sarcoma\u2014a systematic review","volume":"2018","author":"Tenneti","year":"2018","journal-title":"Am Soc Hematology"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0031-3955(16)38084-1","article-title":"Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation","volume":"38","author":"Seeger","year":"1991","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1705224","article-title":"Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors","volume":"37","author":"Fraser","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0013","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2001.19.11.2812","article-title":"High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis","volume":"19","author":"Meyers","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0014","first-page":"2011","article-title":"Current therapeutic approaches in metastatic and recurrent Ewing sarcoma","author":"Huang","year":"2010","journal-title":"Sarcoma"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0015","first-page":"323","article-title":"Busulphan and melphalan prior to autologous bone marrow transplantation","volume":"12","author":"Srivastava","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bmt.1700992","article-title":"High-dose busulphan\/melphalan with autologous stem cell rescue in Ewing's sarcoma","volume":"20","author":"Atra","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0017","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bmt.1702042","article-title":"High-dose busulfan\/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors","volume":"24","author":"Diaz","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0018","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/pbc.20719","article-title":"Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors","volume":"47","author":"Hunold","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0019","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1200\/JCO.2001.19.15.3463","article-title":"Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study","volume":"19","author":"Saylors","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0020","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2008.19.1478","article-title":"Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study","volume":"27","author":"Granowetter","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0021","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0022","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0023","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2009.22.9864","article-title":"Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial","volume":"28","author":"Ladenstein","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0024","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.2018.78.2516","article-title":"High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008","volume":"36","author":"Whelan","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0025","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/annonc\/mdq573","article-title":"Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group\/Scandinavian Sarcoma Group III protocol","volume":"22","author":"Ferrari","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0026","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1200\/JCO.1993.11.10.1911","article-title":"Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma","volume":"11","author":"Horowitz","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0027","first-page":"697","article-title":"Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry","volume":"15","author":"Ladenstein","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0028","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.coc.0000156921.28880.e1","article-title":"long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor","volume":"28","author":"Laurence","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0029","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/bmt.2008.2","article-title":"Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma","volume":"41","author":"Gardner","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2001.19.3.870","article-title":"How effective is dose-intensive\/myeloablative therapy against Ewing's sarcoma\/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0031","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2005.05.105","article-title":"Survival after recurrence of Ewing's sarcoma family of tumors","volume":"23","author":"Barker","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0032","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/annonc\/mdl108","article-title":"High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours","volume":"17","author":"McTiernan","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0033","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2008-1043801","article-title":"High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma","volume":"211","author":"Fr\u00f6hlich","year":"1999","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0034","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1993.11.8.1482","article-title":"Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma","volume":"11","author":"Burdach","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3345\/kjp.2013.56.9.401","article-title":"High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumors","volume":"56","author":"Seo","year":"2013","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0036","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.10546","article-title":"Treosulfan-based high-dose chemotherapy with autologous stem cell transplantation in high-risk Ewing sarcoma","volume":"27","author":"Juergens","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0037","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cncr.24740","article-title":"The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)","volume":"116","author":"Haeusler","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0038","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1200\/JCO.2000.18.17.3108","article-title":"Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group","volume":"18","author":"Cotterill","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0039","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.1998.16.9.3044","article-title":"Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients","volume":"16","author":"Paulussen","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1008208511815","article-title":"Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies","volume":"9","author":"Paulussen","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0041","article-title":"Therapiem\u00f6glichkeiten f\u00fcr Patienten mit prim\u00e4r metastasiertem Ewing-Sarkom: eine Analyse der nach der Cooperativen Ewing-Sarkom-Studie CESS 81 behandelten Patienten","author":"Huckels-Klasen","year":"1991","journal-title":"Uitgever Niet Vastgesteld"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0042","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2008-1033717","article-title":"Results of treatment of primary metastatic Ewing sarcoma: a retrospective analysis of 48 patients [in German]","volume":"200","author":"Wessalowski","year":"1988","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1040-8428(01)00154-8","article-title":"High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)","volume":"41","author":"Burdach","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0044","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2003.12.039","article-title":"High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation","volume":"21","author":"Burdach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0045","doi-asserted-by":"crossref","first-page":"70959","DOI":"10.18632\/oncotarget.10938","article-title":"Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow","volume":"7","author":"Thiel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1398-2265.2004.00186.x","article-title":"Treatment of advanced Ewing tumors by combined radiochemotherapy and engineered cellular transplants","volume":"8","author":"Burdach","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0047","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/pbc.25042","article-title":"The value of high\u2010dose chemotherapy in patients with first relapsed Ewing sarcoma","volume":"61","author":"Rasper","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0048","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1096-911X(200005)34:5<328::AID-MPO3>3.0.CO;2-4","article-title":"Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor\u2010risk Ewing\u2010sarcoma\u2010family tumors","volume":"34","author":"Hawkins","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bbmt.2020.09.029_bib0049","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1705625","article-title":"High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas","volume":"39","author":"Yamada","year":"2007","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120306224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120306224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:31:18Z","timestamp":1761089478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120306224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1083879120306224"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.09.029","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}